Oncoclínicas registers BRL 679.4m net revenue in 3Q21, up 29.4% over 3Q2O
Oncoclínicas registra receita líquida de BRL 679,4m no 3T21, aumento de 29,4% em relação ao 3T20
Intel ID : 334986
|
||||
Relevant Documents
| Press Release | 18 Nov 2021 | Oncoclinicas_Release3T21_2021.pdf | PT |
|
| Intel ID | 334986 | |
| Value | EUR 109,13m | |
| Native Currency |
Brazilian Real (BRL)
Exchange Rate:  |
|
|
Financial Data - Oncoclínicas
(31 Dec 2023) |
Revenue: - EBITDA: - Net Debt: - |
|
| Date |
|
|
| Country |  |
|
| Geography | |
|
| Subsector (Old TTR Sectors) |
|
|
| Type |
|
|
| Intel Grade |
|
|
| Source |
|
|
| Tags | |
Target
| Name |
|
||
| Subsector (Old TTR Sectors) |
|
||
| Primary Sector (TTRSC) |
30.05.11 Oncology 30 Healthcare / 30.05 Specialized Medicine |
||
| Country |
|
||
| Website |
|
||
| Description |
|
Legend:
Verified: Confirmed as a party to an active or possible transaction.
Potential: Unconfirmed as a party to an active or possible transaction.
Retained: Confirmed as “Retained” with a general or specific mandate.
Prospect: Advisory “Prospect” in discussions with or pitching services to possible client.
Transactional data is continuously updated by the research team and therefore is subject to change.